User profiles for M. Boada

Mercè Boada, MD, PhD

Neuróloga. MD, PhD
Verified email at fundacioace.com
Cited by 34049

Analysis of shared heritability in common disorders of the brain

…, A McQuillin, A Al-Chalabi, JC Bis, A Ruiz, M Boada… - Science, 2018 - science.org
INTRODUCTION Brain disorders may exhibit shared symptoms and substantial epidemiological
comorbidity, inciting debate about their etiologic overlap. However, detailed study of …

Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies

…, RE Amariglio, LM Berman, M Boada… - Journal of …, 2015 - content.iospress.com
Research increasingly suggests that subjective cognitive decline (SCD) in older adults, in
the absence of objective cognitive dysfunction or depression, may be a harbinger of non-…

[HTML][HTML] Cognitive and neuropsychiatric manifestations of COVID-19 and effects on elderly individuals with dementia

…, M Marquié, A Ruiz, M Boada - Frontiers in aging …, 2020 - frontiersin.org
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) has rapidly spread worldwide and has had unprecedented …

[HTML][HTML] New insights into the genetic etiology of Alzheimer's disease and related dementias

…, V Bessi, G Binetti, A Bizarro, R Blesa, M Boada… - Nature …, 2022 - nature.com
Abstract Characterization of the genetic landscape of Alzheimer’s disease (AD) and related
dementias (ADD) provides a unique opportunity for a better understanding of the associated …

Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

…, B Dubois, L Eisner, S Flitman, BF Michel, M Boada… - Neurology, 2003 - AAN Enterprises
Background: AD is characterized by cerebral deposition of β-amyloid plaques with amyloid β-peptide
(Aβ) 42 as the major peptide constituent, along with neurofibrillary tangles and …

Genetic meta-analysis of diagnosed Alzheimer's disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

…, BN Vardarajan, J Epelbaum, P Hoffmann, M Boada… - Nature …, 2019 - nature.com
Risk for late-onset Alzheimer’s disease (LOAD), the most prevalent dementia, is partially
driven by genetics. To identify LOAD risk loci, we performed a large genome-wide association …

Genome-wide analysis of genetic loci associated with Alzheimer disease

…, MA Ikram, AL DeStefano, V Gudnason, M Boada… - Jama, 2010 - jamanetwork.com
Context Genome-wide association studies (GWAS) have recently identified CLU, PICALM,
and CR1 as novel genes for late-onset Alzheimer disease (AD). Objectives To identify and …

[HTML][HTML] Trial of solanezumab for mild dementia due to Alzheimer's disease

…, B Vellas, M Woodward, M Boada… - … England Journal of …, 2018 - Mass Medical Soc
Background Alzheimer’s disease is characterized by amyloid-beta (Aβ) plaques and
neurofibrillary tangles. The humanized monoclonal antibody solanezumab was designed to …

A global change‐induced biome shift in the Montseny mountains (NE Spain)

J Penuelas, M Boada - Global change biology, 2003 - Wiley Online Library
… 70 m at the highest altitudes (1600–1700 m). Both the beech forests and the heather (Calluna
vulgaris) heathlands are being replaced by holm oak (Quercus ilex) forest at medium …

Duration of preclinical, prodromal, and dementia stages of Alzheimer's disease in relation to age, sex, and APOE genotype

…, E Salmon, JP Michel, DS Zekry, M Boada… - Alzheimer's & …, 2019 - Elsevier
Introduction We estimated the age-specific duration of the preclinical, prodromal, and dementia
stages of Alzheimer's disease (AD) and the influence of sex, setting, apolipoprotein E (…